Brain Connect 13:164173 Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, Li S, Hong S, Zhang R, Xie J, Kornilov SA, Scherler K, Pavlovitch-Bedzyk AJ, Dong S, Lausted C, Lee I, Fallen S, Dai CL, Baloni P, Smith B, Duvvuri VR, Anderson KG, Li J, Yang F, Duncombe CJ, McCulloch DJ, Rostomily C, Troisch P, Zhou J, Mackay S, DeGottardi Q, May DH, Taniguchi R, Gittelman RM, Klinger M, Snyder TM, Roper R, Wojciechowska G, Murray K, Edmark R, Evans S, Jones L, Zhou Y, Rowen L, Liu R, Chour W, Algren HA, Berrington WR, Wallick JA, Cochran RA, Micikas ME, Unit IS-SC-B, Wrin T, Petropoulos CJ, Cole HR, Fischer TD, Wei W, Hoon DSB, Price ND, Subramanian N, Hill JA, Hadlock J, Magis AT, Ribas A, Lanier LL, Boyd SD, Bluestone JA, Chu H, Hood L, Gottardo R, Greenberg PD, Davis MM, Goldman JD, Heath JR (2022) Multiple early factors anticipate post-acute Covid-19 sequelae
They ran large-scale clinical trials, navigated regulatory hurdles, and scaled up manufacturing
En 1923 fue de las primeras compaas en producir insulina para el tratamiento de la diabetes, un padecimiento relacionado con la obesidad, la cual ha sido una de sus principales ramas de oferta de tratamientos
Acta Med Scand 1980;208:209-12
"We see opportunity within our unique snacking portfolio," Tom McGough, cochief operating officer with Conagra Brands, told analysts at the Consumer Analyst Group of New York conference in Florida in February of 2024 about the potential to get more GLP-1 users and protein-conscious consumers back onboard with its brands
